AA
54
-7
BRK.B
40
15
AKAM
42
2
ALL
66
13
BAC
62
3
BIIB
51
-5
AVY
37
-4
BAX
38
-3
AEP
64
-3
AIV
47
10
AON
63
-2
ACN
42
2
AXP
62
2
AMGN
25
-5
ABT
47
-3
APD
45
-4
AIZ
76
-2
AAPL
49
-3
APH
59
3
AEE
64
-2
AA
54
-7
BRK.B
40
15
AKAM
42
2
ALL
66
13
BAC
62
3
BIIB
51
-5
AVY
37
-4
BAX
38
-3
AEP
64
-3
AIV
47
10
AON
63
-2
ACN
42
2
AXP
62
2
AMGN
25
-5
ABT
47
-3
APD
45
-4
AIZ
76
-2
AAPL
49
-3
APH
59
3
AEE
64
-2
Financhill
Back

Adverum Biotechnologies 10K Form

Sell
35

ADVM
Adverum Biotechnologies

Last Price:
$2.89
Seasonality Move:
-15.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADVM News And Ratings

See the #1 stock for the next 7 days that we like better than ADVM

ADVM Financial Statistics

Sales & Book Value

Annual Sales: $1M
Cash Flow: $-38.9M
Price / Cash Flow: 0
Annual Sales: $-0.96
Price / Book: 1.95

Profitability

EPS (TTM): -7.85000
Net Income (TTM): $-164.3M
Gross Margin: $-2.7M
Return on Equity: -211.12%
Return on Assets: -91.08%

Adverum Biotechnologies Earnings Forecast

Key Adverum Biotechnologies Financial Ratios

  • The Gross Profit Margin over the past 5 years for ADVM is -265.30%.
  • The Selling, General & Administrative Expenses for ADVM have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 7,704.10% of Revenue.
  • The Net Earning history of ADVM is -13,092.70% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

Adverum Biotechnologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADVM
CUSIP: 00773U
Website: adverum.com

Debt

Debt-to-Equity Ratio: -4.56
Current Ratio: 1.54
Quick Ratio: 1.42

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADVM Technical Analysis vs Fundamental Analysis

Sell
35
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy or a Sell?